The global OPO Infant Formula Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Cow Milk Formula, Goat Milk Formula), By Application (0 to 6 Months, 6 to 12 Months, 12 to 36 Months)
In 2024, the OPO infant formula market is thriving, fueled by the demand for high-quality infant nutrition that mimics the benefits of breast milk. OPO (Oleic-Palmitic-Oleic) structured lipids are designed to support optimal fat absorption and bone health in infants. The market benefits from advancements in lipid formulation and infant nutrition research that enhance product efficacy. The trend towards clean label and natural ingredients is influencing product development. Increasing awareness of the importance of early nutrition and the popularity of premium infant formulas are further supporting market growth.
The market report analyses the leading companies in the industry including Abbott Laboratories, Ausnutria, Beingmate, BiosTime, Brightdairy, Deloraine, Feihe, HERDS, Kabrita, Milupa, Nutriben, Shanxi Yatai, Wyeth Nutrition, Yili, and Others.
The most prominent trend in the OPO Infant Formula Market is the increasing focus on digestive health in infants. OPO (oleic-palmitic-oleic) structured lipids are being incorporated into infant formulas to mimic the fat composition of human milk, which promotes better digestion and nutrient absorption. This trend is driven by the desire to provide infants with formulas that support optimal growth and development.
A key driver in the OPO Infant Formula Market is health consciousness and parental demand for premium products. As parents become more aware of the importance of early nutrition, there is a rising demand for infant formulas that offer superior nutritional benefits and closely resemble human milk. This demand supports the growth of the market as parents seek the best possible nutrition for their babies.
One significant opportunity in the OPO Infant Formula Market lies in innovation in infant formula formulations. Companies can develop new products that incorporate OPO lipids along with other beneficial ingredients, such as probiotics and prebiotics, to enhance the overall health benefits of the formula. By offering advanced and scientifically backed formulations, manufacturers can attract health-conscious parents and drive market growth.
In the OPO Infant Formula Market, Cow Milk Formula is the largest segment. This dominance is primarily due to the widespread use and established preference for cow milk-based formulas, which have been a standard choice for infant nutrition for many years. Cow milk formulas are widely available, cost-effective, and well-researched, making them a popular option among parents. The extensive availability of cow milk formulas in various formulations and the established trust in their nutritional adequacy contribute to their position as the largest segment in the market.
The 0 to 6 Months age group is poised to grow the fastest in the OPO Infant Formula Market over the next five years. This growth is driven by the increasing awareness of the benefits of optimal protein and fat composition in early infant development, particularly for newborns and infants in this critical growth phase. The focus on supporting early-stage nutrition, combined with growing consumer education on infant health and nutrition, contributes to the rapid expansion of this segment. Additionally, advancements in infant formula technology and the increasing availability of specialized formulas for this age group further fuel its growth.
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Ausnutria
Beingmate
BiosTime
Brightdairy
Deloraine
Feihe
HERDS
Kabrita
Milupa
Nutriben
Shanxi Yatai
Wyeth Nutrition
Yili
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to OPO Infant Formula Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. OPO Infant Formula Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global OPO Infant Formula Market Share by Company, 2023
4.1.2. Product Offerings of Leading OPO Infant Formula Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. OPO Infant Formula Market Drivers
6.2. OPO Infant Formula Market Challenges
6.6. OPO Infant Formula Market Opportunities
6.4. OPO Infant Formula Market Trends
Chapter 7. Global OPO Infant Formula Market Outlook Trends
7.1. Global OPO Infant Formula Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global OPO Infant Formula Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global OPO Infant Formula Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 8. Global OPO Infant Formula Regional Analysis and Outlook
8.1. Global OPO Infant Formula Revenue (USD Million) By Regions (2021- 2032)
8.2. North America OPO Infant Formula Revenue (USD Million) by Country (2021-2032)
8.2.1. United States OPO Infant Formula Regional Analysis and Outlook
8.2.2. Canada OPO Infant Formula Regional Analysis and Outlook
8.2.3. Mexico OPO Infant Formula Regional Analysis and Outlook
8.3. Europe OPO Infant Formula Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany OPO Infant Formula Regional Analysis and Outlook
8.3.2. France OPO Infant Formula Regional Analysis and Outlook
8.3.3. United Kingdom OPO Infant Formula Regional Analysis and Outlook
8.3.4. Spain OPO Infant Formula Regional Analysis and Outlook
8.3.5. Italy OPO Infant Formula Regional Analysis and Outlook
8.3.6. Russia OPO Infant Formula Regional Analysis and Outlook
8.3.7. Rest of Europe OPO Infant Formula Regional Analysis and Outlook
8.4. Asia Pacific OPO Infant Formula Revenue (USD Million) by Country (2021-2032)
8.4.1. China OPO Infant Formula Regional Analysis and Outlook
8.4.2. Japan OPO Infant Formula Regional Analysis and Outlook
8.4.3. India OPO Infant Formula Regional Analysis and Outlook
8.4.4. South Korea OPO Infant Formula Regional Analysis and Outlook
8.4.5. Australia OPO Infant Formula Regional Analysis and Outlook
8.4.6. South East Asia OPO Infant Formula Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific OPO Infant Formula Regional Analysis and Outlook
8.5. South America OPO Infant Formula Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil OPO Infant Formula Regional Analysis and Outlook
8.5.2. Argentina OPO Infant Formula Regional Analysis and Outlook
8.5.3. Rest of South America OPO Infant Formula Regional Analysis and Outlook
8.6. Middle East and Africa OPO Infant Formula Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East OPO Infant Formula Regional Analysis and Outlook
8.6.2. Africa OPO Infant Formula Regional Analysis and Outlook
Chapter 9. North America OPO Infant Formula Analysis and Outlook
9.1. North America OPO Infant Formula Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America OPO Infant Formula Revenue (USD Million) by Type (2021-2032)
9.1.2. North America OPO Infant Formula Revenue (USD Million) by Application (2021-2032)
9.1.3. North America OPO Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 10. Europe OPO Infant Formula Analysis and Outlook
10.1. Europe OPO Infant Formula Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe OPO Infant Formula Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe OPO Infant Formula Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe OPO Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 11. Asia Pacific OPO Infant Formula Analysis and Outlook
11.1. Asia Pacific OPO Infant Formula Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific OPO Infant Formula Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific OPO Infant Formula Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific OPO Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 12. South America OPO Infant Formula Analysis and Outlook
12.1. South America OPO Infant Formula Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America OPO Infant Formula Revenue (USD Million) by Type (2021-2032)
12.1.2. South America OPO Infant Formula Revenue (USD Million) by Application (2021-2032)
12.1.3. South America OPO Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 13. Middle East and Africa OPO Infant Formula Analysis and Outlook
13.1. Middle East and Africa OPO Infant Formula Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa OPO Infant Formula Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa OPO Infant Formula Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa OPO Infant Formula Revenue (USD Million) by Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Chapter 14. OPO Infant Formula Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Abbott Laboratories
Ausnutria
Beingmate
BiosTime
Brightdairy
Deloraine
Feihe
HERDS
Kabrita
Milupa
Nutriben
Shanxi Yatai
Wyeth Nutrition
Yili
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global OPO Infant Formula Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global OPO Infant Formula Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global OPO Infant Formula Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global OPO Infant Formula Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global OPO Infant Formula Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global OPO Infant Formula Market Share (%) By Regions (2021-2032)
Table 12 North America OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 13 Europe OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 15 South America OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Table 17 North America OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 18 North America OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 19 North America OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 20 Europe OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 21 Europe OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 22 Europe OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 26 South America OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 27 South America OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 28 South America OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global OPO Infant Formula Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global OPO Infant Formula Market Share (%) By Regions (2023)
Figure 6. North America OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 7. United States OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 12. France OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 12. China OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 14. India OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 18. South America OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific OPO Infant Formula Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa OPO Infant Formula Revenue (USD Million) By Region (2021-2032)
Figure 28. North America OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 29. North America OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 30. North America OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 37. South America OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 38. South America OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 39. South America OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa OPO Infant Formula Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa OPO Infant Formula Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa OPO Infant Formula Revenue (USD Million) By Product (2021-2032)
By Type
Cow Milk Formula
Goat Milk Formula
By Application
0 to 6 Months
6 to 12 Months
12 to 36 Months
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global OPO Infant Formula Market Size is valued at $XX Million in 2024 and is forecast to register a growth rate (CAGR) of 9.2% to reach $XX Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Ausnutria, Beingmate, BiosTime, Brightdairy, Deloraine, Feihe, HERDS, Kabrita, Milupa, Nutriben, Shanxi Yatai, Wyeth Nutrition, Yili
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume